Systematic Exploration of Functional Group Relevance for Anti-Leishmanial Activity of Anisomycin

Author:

Nguyen Anh Minh Thao1,Shalev-Benami Moran2,Rosa-Teijeiro Chloé34,Ibarra-Meneses Ana Victoria34,Yonath Ada2,Bashan Anat2,Jaffe Charles L.5,Olivier Martin67ORCID,Fernandez-Prada Christopher34ORCID,Lubell William D.1ORCID

Affiliation:

1. Department of Chemistry, Université de Montréal, Montreal, QC H3T 1J4, Canada

2. Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel

3. Department of Pathology and Microbiology, Faculty of Veterinary Medicine, Université de Montréal, Saint-Hyacinthe, QC J2S 2M2, Canada

4. The Research Group on Infectious Diseases in Production Animals (GREMIP), Faculty of Veterinary Medicine, Université de Montréal, Montreal, QC J2S 2M2, Canada

5. Department of Microbiology & Molecular Genetics, Kuvin Center for the Study of Tropical & Infectious Diseases, Institute for Medical Research (IMRIC), Hadassah Hebrew University Medical Center, Jerusalem 9112102, Israel

6. Departments of Medicine, and of Microbiology and Immunology, Faculty of Medicine, McGill University, Montreal, QC H3A 2B4, Canada

7. The Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, QC H4A 3J1, Canada

Abstract

Assessment of structure–activity relationships for anti-protozoan activity revealed a strategy for preparing potent anisomycin derivatives with reduced host toxicity. Thirteen anisomycin analogs were synthesized by modifying the alcohol, amine, and aromatic functional groups. Examination of anti-protozoal activity against various strains of Leishmania and cytotoxicity against leucocytes with comparison against the parent natural product demonstrated typical losses of activity with modifications of the alcohol, amine, and aromatic meta-positions. On the other hand, the para-phenol moiety of anisomycin proved an effective location for introducing substituents without significant loss of anti-protozoan potency. An entry point for differentiating activity against Leishmania versus host has been uncovered by this systematic study.

Funder

New Frontiers in Research Fund Exploration

Canadian Institutes of Health Research

Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant Program Projects

Fonds de recherche du Québec—Nature et technologies (FRQNT) Centre in Green Chemistry and Catalysis

Canada Foundation for Innovation

FRQNT and the NSERC studentship programs

UM-Israel Partnership for Research, the Weizmann Abroad Postdoctoral Program for Advancing Women in Science

Penny Feiwel Chair for Research in Dermatology

Publisher

MDPI AG

Subject

General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)

Reference48 articles.

1. Anisomycin, 1 A new anti-protozoan antibiotic;Sobin;J. Am. Chem. Soc.,1954

2. Inhibitors of protein biosynthesis: II. Mode of action of anisomycin;Grollman;J. Biol. Chem.,1967

3. Anisomycin is a multifunctional drug: More than just a tool to inhibit protein synthesis;Curr. Chem. Biol.,2010

4. Structural basis for the inhibition of the eukaryotic ribosome;Prokhorova;Nature,2014

5. Signalling and superinduction;Mahadevan;Nature,1991

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3